Search Results

Analyzing the Impact of INSTEAD at 5 Years

Matt M. Thompson, MD, FRCS, discusses the long-term results of INSTEAD with Principal Investigator Christoph A. Nienaber, MD, and their influence on treatment protocols for aortic dissection.

Advances in Treating Thoracic Aortic Dissection

By Matt M. Thompson, MD, FRCS, and Michael D. Dake, MD

The Value of TEVAR Trials

Do we need more trials to tell us how and when to treat descending thoracic aortic aneurysms?

By Benjamin O. Patterson, PhD, MRCS, and Matt M. Thompson, MD, FRCS

Standard EVAR for the 10-mm Neck

A comprehensive strategy composed of the essential experience and technology needed to achieve satisfactory outcomes when treating short-necked aneurysms.

By Amir H. Malkawi, MD, FRCS; Matt M. Thompson, MD, FRCS; and Ian M. Loftus, MD, FRCS

Trends in TEVAR

By Edward Y. Woo, MD, and Ian M. Loftus, MD, FRCS

The VIRTUE Registry

The VIRTUE registry is designed to assess thoracic endografting with the Valiant Stent Graft System for the treatment of type B aortic dissections.

By Matt Thompson, MD, FRCS

EVAR's Continued Progress and Questions on the Horizon

By Ronald M. Fairman, MD, and Edward Y. Woo, MD

Chronic Aneurysmal Aortic Dissection

A staged hybrid procedure and a fenestrated endograft were used to treat this challenging presentation.

By R. M. Walkden, MRCS, FRCR; Rob A. Morgan, MRCP, FRCR; Ian Loftus, MD, FRCS; and Matt Thompson, MB, FRCS

Meeting the Challenge

By Barry T. Katzen, MD, Chief Medical Editor

Evaluating Thoracic Aortic Therapy

By Takao Ohki, MD, PhD, Chief Medical Editor